WilliamTeo的个人主页 - 老虎社区

WilliamTeo

WilliamTeo

暂无个人介绍

IP属地：未知

130关注

6粉丝

0主题

0勋章

2021-08-13

Good

抱歉，原内容已删除

2021-08-12

All the way

BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster

2021-08-10

Lose money

2021-08-10

To the sun

AMC shares rose 7% in premarket trading.

2021-08-10

Pro

Moderna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time

2021-08-06

All the way

抱歉，原内容已删除

2021-07-31

To the sun

2021-07-29

$Ebang International Holdings Inc.(EBON)$not meant to be

2021-07-23

Trash stock

2021-07-23

To the moon

抱歉，原内容已删除

2021-07-21

Unreasonable

2021-07-17

$Gaotu Techedu Inc.(GOTU)$omg. Trash stock

2021-07-15

Up the lorry

2021-07-15

All the way

UnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate

2021-07-15

All the way down

UnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate

2021-07-12

Slowly but surely. Target $18

2021-07-12

Wow this

抱歉，原内容已删除

2021-07-12

Good read

抱歉，原内容已删除

2021-07-10

All the way

2021-07-10

Lets go

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3575416215572570","uuid":"3575416215572570","gmtCreate":1612342668405,"gmtModify":1613096802979,"name":"WilliamTeo","pinyin":"williamteo","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":130,"tweetSize":174,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.03","exceedPercentage":"93.75%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":"80.68%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":894761578,"gmtCreate":1628858017494,"gmtModify":1631892264502,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894761578","repostId":"2159294386","repostType":4,"isVote":1,"tweetType":1,"viewCount":2108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894990649,"gmtCreate":1628780633881,"gmtModify":1631892264507,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way","listText":"All the way","text":"All the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/894990649","repostId":"2158325931","repostType":4,"repost":{"id":"2158325931","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628776169,"share":"https://www.laohu8.com/m/news/2158325931?lang=&edition=full","pubTime":"2021-08-12 21:49","market":"us","language":"en","title":"BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster","url":"https://stock-news.laohu8.com/highlight/detail?id=2158325931","media":"Tiger Newspress","summary":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previo","content":"<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-12 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158325931","content_text":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.\n\nBioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.\nThe WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.\nThere is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.\nBioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.\nThe conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.\nPfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":952,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896402641,"gmtCreate":1628599016083,"gmtModify":1631892264511,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Lose money","listText":"Lose money","text":"Lose money","images":[{"img":"https://static.tigerbbs.com/942135289525db288b1954e466ab1309","width":"1080","height":"3610"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/896402641","isVote":1,"tweetType":1,"viewCount":2435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":896406724,"gmtCreate":1628598970368,"gmtModify":1631892264513,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"To the sun","listText":"To the sun","text":"To the sun","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/896406724","repostId":"1116005404","repostType":4,"repost":{"id":"1116005404","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628582673,"share":"https://www.laohu8.com/m/news/1116005404?lang=&edition=full","pubTime":"2021-08-10 16:04","market":"us","language":"en","title":"AMC shares rose 7% in premarket trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=1116005404","media":"Tiger Newspress","summary":"AMC shares rose 7% in premarket trading.\nAMC Entertainment reported a narrower than expected loss fo","content":"<p>AMC&nbsp;shares rose 7% in premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/692b6fc550595ea189d7b6697732bdac\" tg-width=\"854\" tg-height=\"608\" referrerpolicy=\"no-referrer\">AMC Entertainment&nbsp;reported&nbsp;a narrower than expected loss for the second quarter while revenue topped estimates.</p>\n<p>AMC&nbsp;will begin accepting apex cryptocurrency&nbsp;<b>Bitcoin</b>&nbsp;as payment for move tickets and concessions by the end of this&nbsp;year.</p>\n<p>“By year end, we will have the information technology system in place to accept Bitcoin as payment for movie tickets and concessions if purchased online at all of our U.S. theatres,” AMC Entertainment CEO&nbsp;<b>Adam Aron</b>&nbsp;said on&nbsp;the Q2 earnings call on Monday.</p>\n<p>Aron added that AMC Entertainment is in the preliminary stages of exploring how else the company can participate in the new “burgeoning cryptocurrency universe.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC shares rose 7% in premarket trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC shares rose 7% in premarket trading.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-10 16:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AMC&nbsp;shares rose 7% in premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/692b6fc550595ea189d7b6697732bdac\" tg-width=\"854\" tg-height=\"608\" referrerpolicy=\"no-referrer\">AMC Entertainment&nbsp;reported&nbsp;a narrower than expected loss for the second quarter while revenue topped estimates.</p>\n<p>AMC&nbsp;will begin accepting apex cryptocurrency&nbsp;<b>Bitcoin</b>&nbsp;as payment for move tickets and concessions by the end of this&nbsp;year.</p>\n<p>“By year end, we will have the information technology system in place to accept Bitcoin as payment for movie tickets and concessions if purchased online at all of our U.S. theatres,” AMC Entertainment CEO&nbsp;<b>Adam Aron</b>&nbsp;said on&nbsp;the Q2 earnings call on Monday.</p>\n<p>Aron added that AMC Entertainment is in the preliminary stages of exploring how else the company can participate in the new “burgeoning cryptocurrency universe.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116005404","content_text":"AMC shares rose 7% in premarket trading.\nAMC Entertainment reported a narrower than expected loss for the second quarter while revenue topped estimates.\nAMC will begin accepting apex cryptocurrency Bitcoin as payment for move tickets and concessions by the end of this year.\n“By year end, we will have the information technology system in place to accept Bitcoin as payment for movie tickets and concessions if purchased online at all of our U.S. theatres,” AMC Entertainment CEO Adam Aron said on the Q2 earnings call on Monday.\nAron added that AMC Entertainment is in the preliminary stages of exploring how else the company can participate in the new “burgeoning cryptocurrency universe.”","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896406617,"gmtCreate":1628598943439,"gmtModify":1631892264519,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Pro","listText":"Pro","text":"Pro","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/896406617","repostId":"1122891084","repostType":4,"repost":{"id":"1122891084","kind":"news","pubTimestamp":1628585720,"share":"https://www.laohu8.com/m/news/1122891084?lang=&edition=full","pubTime":"2021-08-10 16:55","market":"us","language":"en","title":"Moderna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time","url":"https://stock-news.laohu8.com/highlight/detail?id=1122891084","media":"Seeking Alpha","summary":"According to two reports published in medRxiv, the mRNA vaccine developed by Pfizer and BioNTech SE ","content":"<ul>\n <li>According to two reports published in medRxiv, the mRNA vaccine developed by <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>&nbsp;may be less effective than <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>'s&nbsp;against the Delta variant of the coronavirus,&nbsp;<i>Reuters reports</i>.</li>\n <li>The study, yet to be peer reviewed, included more than 50,000 patients in the Mayo Clinic Health System.</li>\n <li>Researchers found that efficacy of Moderna's Covid-19 vaccine dropped to 76% in July - when the Delta variant was predominant - from 86% in early 2021.</li>\n <li>However, during the same time, Pfizer/BioNTech vaccine's effectiveness decreased to 42% from 76%.</li>\n <li>While both vaccines remain effective at preventing Covid hospitalization, a Moderna booster shot may be necessary soon for people who got Pfizer or Moderna vaccines earlier this year, said Dr. Venky Soundararajan of Massachusetts data analytics company, who led the Mayo study.</li>\n <li>In a separate study, elderly nursing home residents in Ontario produced stronger immune responses - especially against variants - after the Moderna shot than after Pfizer/BioNTech vaccine.</li>\n <li>\"We continue to believe... a third dose booster may be needed within 6 to 12 months after full vaccination to maintain the highest levels of protection,\" said a Pfizer spokesperson.</li>\n <li>In a study&nbsp;posted on medRxiv, it was observed that breakthrough COVID-19 odds rise months after vaccination.</li>\n <li>The data suggested that people who received their second dose of the Pfizer/BioNTech vaccine five or more months ago are more likely to test positive for COVID-19 than people who were fully vaccinated less than five months ago.</li>\n <li>Overall, 1.8% of individulas tested positive in a research including nearly 34,000 fully vaccinated adults in Israel which were tested to see if they had a breakthrough case of COVID-19.</li>\n <li>At all ages, the odds of testing positive were higher when the last vaccine dose was received at least 146 days earlier.</li>\n <li>Among patients older than 60, the odds of a positive test were almost three times higher when 146 days had passed since the second dose.</li>\n <li>\"Very few patients had required hospitalization, and it is too early to assess the severity of these new infections in terms of hospital admission, need for mechanical ventilation or mortality,\" he added. \"We are planning to continue our research,\" said coauthor Dr. Eugene Merzon of Leumit Health Services in Israel.</li>\n <li>Israel has already started administering booster shots to people over the age of 60.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-10 16:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3727988-moderna-covid-19-vaccine-may-be-better-than-pfizer-against-delta-variant-breakthrough-cases-rise-with-time><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>According to two reports published in medRxiv, the mRNA vaccine developed by Pfizer and BioNTech SE may be less effective than Moderna, Inc.'s against the Delta variant of the coronavirus, Reuters ...</p>\n\n<a href=\"https://seekingalpha.com/news/3727988-moderna-covid-19-vaccine-may-be-better-than-pfizer-against-delta-variant-breakthrough-cases-rise-with-time\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"source_url":"https://seekingalpha.com/news/3727988-moderna-covid-19-vaccine-may-be-better-than-pfizer-against-delta-variant-breakthrough-cases-rise-with-time","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122891084","content_text":"According to two reports published in medRxiv, the mRNA vaccine developed by Pfizer and BioNTech SE may be less effective than Moderna, Inc.'s against the Delta variant of the coronavirus, Reuters reports.\nThe study, yet to be peer reviewed, included more than 50,000 patients in the Mayo Clinic Health System.\nResearchers found that efficacy of Moderna's Covid-19 vaccine dropped to 76% in July - when the Delta variant was predominant - from 86% in early 2021.\nHowever, during the same time, Pfizer/BioNTech vaccine's effectiveness decreased to 42% from 76%.\nWhile both vaccines remain effective at preventing Covid hospitalization, a Moderna booster shot may be necessary soon for people who got Pfizer or Moderna vaccines earlier this year, said Dr. Venky Soundararajan of Massachusetts data analytics company, who led the Mayo study.\nIn a separate study, elderly nursing home residents in Ontario produced stronger immune responses - especially against variants - after the Moderna shot than after Pfizer/BioNTech vaccine.\n\"We continue to believe... a third dose booster may be needed within 6 to 12 months after full vaccination to maintain the highest levels of protection,\" said a Pfizer spokesperson.\nIn a study posted on medRxiv, it was observed that breakthrough COVID-19 odds rise months after vaccination.\nThe data suggested that people who received their second dose of the Pfizer/BioNTech vaccine five or more months ago are more likely to test positive for COVID-19 than people who were fully vaccinated less than five months ago.\nOverall, 1.8% of individulas tested positive in a research including nearly 34,000 fully vaccinated adults in Israel which were tested to see if they had a breakthrough case of COVID-19.\nAt all ages, the odds of testing positive were higher when the last vaccine dose was received at least 146 days earlier.\nAmong patients older than 60, the odds of a positive test were almost three times higher when 146 days had passed since the second dose.\n\"Very few patients had required hospitalization, and it is too early to assess the severity of these new infections in terms of hospital admission, need for mechanical ventilation or mortality,\" he added. \"We are planning to continue our research,\" said coauthor Dr. Eugene Merzon of Leumit Health Services in Israel.\nIsrael has already started administering booster shots to people over the age of 60.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2561,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893119227,"gmtCreate":1628245138469,"gmtModify":1631892264522,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way","listText":"All the way","text":"All the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/893119227","repostId":"1135651416","repostType":4,"isVote":1,"tweetType":1,"viewCount":1167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806534198,"gmtCreate":1627666751414,"gmtModify":1631892264524,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"To the sun","listText":"To the sun","text":"To the sun","images":[{"img":"https://static.tigerbbs.com/edc1f1e47b16e96a42d7ec21bf988e3c","width":"1080","height":"3691"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806534198","isVote":1,"tweetType":1,"viewCount":2280,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":808042660,"gmtCreate":1627547020950,"gmtModify":1631884531690,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/EBON\">$Ebang International Holdings Inc.(EBON)$</a>not meant to be","listText":"<a href=\"https://laohu8.com/S/EBON\">$Ebang International Holdings Inc.(EBON)$</a>not meant to be","text":"$Ebang International Holdings Inc.(EBON)$not meant to be","images":[{"img":"https://static.tigerbbs.com/481041af7db4ea49f66170c2f8001a68","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/808042660","isVote":1,"tweetType":1,"viewCount":2132,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":175423584,"gmtCreate":1627047386448,"gmtModify":1631892264526,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Trash stock","listText":"Trash stock","text":"Trash stock","images":[{"img":"https://static.tigerbbs.com/c2a7977bbebb8a789f10da9a7ff17a88","width":"1080","height":"3691"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/175423584","isVote":1,"tweetType":1,"viewCount":2258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":175429165,"gmtCreate":1627047351657,"gmtModify":1631892264530,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"To the moon","listText":"To the moon","text":"To the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/175429165","repostId":"2153498346","repostType":4,"isVote":1,"tweetType":1,"viewCount":3092,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176634432,"gmtCreate":1626879223426,"gmtModify":1631892264531,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Unreasonable","listText":"Unreasonable","text":"Unreasonable","images":[{"img":"https://static.tigerbbs.com/c47f8c09fbac996a5bad78b0075ac046","width":"1080","height":"3691"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176634432","isVote":1,"tweetType":1,"viewCount":306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":179393598,"gmtCreate":1626485012014,"gmtModify":1633926368266,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GOTU\">$Gaotu Techedu Inc.(GOTU)$</a>omg. Trash stock","listText":"<a href=\"https://laohu8.com/S/GOTU\">$Gaotu Techedu Inc.(GOTU)$</a>omg. Trash stock","text":"$Gaotu Techedu Inc.(GOTU)$omg. Trash stock","images":[{"img":"https://static.tigerbbs.com/6c28595f6d5a7673fb76b17b1c6320fd","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/179393598","isVote":1,"tweetType":1,"viewCount":1224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":147822526,"gmtCreate":1626351695365,"gmtModify":1633927630673,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Up the lorry&nbsp;","listText":"Up the lorry&nbsp;","text":"Up the lorry","images":[{"img":"https://static.tigerbbs.com/7d195ba504666aa9c1d493e565d9fa90","width":"1080","height":"3571"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147822526","isVote":1,"tweetType":1,"viewCount":461,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":147822270,"gmtCreate":1626351668090,"gmtModify":1633927630795,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way","listText":"All the way","text":"All the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147822270","repostId":"2151251345","repostType":4,"repost":{"id":"2151251345","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626343025,"share":"https://www.laohu8.com/m/news/2151251345?lang=&edition=full","pubTime":"2021-07-15 17:57","market":"us","language":"en","title":"UnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2151251345","media":"Benzinga","summary":"UnitedHealth Group (NYSE:UNH) reported quarterly earnings of $4.70 per share which beat the analyst consensus estimate of $4.43 by 6.09 percent. This is a 33.99 percent decrease over earnings of $7.12 per share from the","content":"<p>UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.</p>\n<p>The industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.</p>\n<p>For the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.</p>\n<p>Nearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.</p>\n<p>Revenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.</p>\n<p>UnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.</p>\n<p>The company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-15 17:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.</p>\n<p>The industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.</p>\n<p>For the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.</p>\n<p>Nearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.</p>\n<p>Revenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.</p>\n<p>UnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.</p>\n<p>The company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QTWO":"Q2 Holdings Inc","UNH":"联合健康"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151251345","content_text":"UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.\nThe industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.\nFor the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.\nNearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.\nRevenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.\nUnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.\nThe company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.","news_type":1,"symbols_score_info":{"QTWO":0.9,"UNH":0.9}},"isVote":1,"tweetType":1,"viewCount":309,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147822126,"gmtCreate":1626351647465,"gmtModify":1633927631162,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way down","listText":"All the way down","text":"All the way down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147822126","repostId":"2151251345","repostType":4,"repost":{"id":"2151251345","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626343025,"share":"https://www.laohu8.com/m/news/2151251345?lang=&edition=full","pubTime":"2021-07-15 17:57","market":"us","language":"en","title":"UnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2151251345","media":"Benzinga","summary":"UnitedHealth Group (NYSE:UNH) reported quarterly earnings of $4.70 per share which beat the analyst consensus estimate of $4.43 by 6.09 percent. This is a 33.99 percent decrease over earnings of $7.12 per share from the","content":"<p>UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.</p>\n<p>The industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.</p>\n<p>For the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.</p>\n<p>Nearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.</p>\n<p>Revenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.</p>\n<p>UnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.</p>\n<p>The company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-15 17:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.</p>\n<p>The industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.</p>\n<p>For the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.</p>\n<p>Nearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.</p>\n<p>Revenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.</p>\n<p>UnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.</p>\n<p>The company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QTWO":"Q2 Holdings Inc","UNH":"联合健康"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151251345","content_text":"UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.\nThe industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.\nFor the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.\nNearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.\nRevenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.\nUnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.\nThe company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.","news_type":1,"symbols_score_info":{"QTWO":0.9,"UNH":0.9}},"isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146539505,"gmtCreate":1626089102907,"gmtModify":1631884663863,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Slowly but surely. Target $18","listText":"Slowly but surely. Target $18","text":"Slowly but surely. Target $18","images":[{"img":"https://static.tigerbbs.com/6bc509e907310e577e7b32e0d7f1bb08","width":"1080","height":"3472"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/146539505","isVote":1,"tweetType":1,"viewCount":442,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":146530565,"gmtCreate":1626089052357,"gmtModify":1633930280406,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Wow this&nbsp;","listText":"Wow this&nbsp;","text":"Wow this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/146530565","repostId":"2150538413","repostType":4,"isVote":1,"tweetType":1,"viewCount":482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146530690,"gmtCreate":1626089026910,"gmtModify":1633930280528,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Good read","listText":"Good read","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/146530690","repostId":"1114863871","repostType":4,"isVote":1,"tweetType":1,"viewCount":501,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141549674,"gmtCreate":1625882430398,"gmtModify":1633936445925,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way","listText":"All the way","text":"All the way","images":[{"img":"https://static.tigerbbs.com/72bbe6a315f54d7217be8dba61768a24","width":"1080","height":"3571"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/141549674","isVote":1,"tweetType":1,"viewCount":416,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":141540425,"gmtCreate":1625882401567,"gmtModify":1633936446741,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Lets go","listText":"Lets go","text":"Lets go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/141540425","repostId":"2150305430","repostType":4,"isVote":1,"tweetType":1,"viewCount":475,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":359501806,"gmtCreate":1616408868405,"gmtModify":1634526005744,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>diamond hand here","listText":"<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>diamond hand here","text":"$GameStop(GME)$diamond hand here","images":[{"img":"https://static.tigerbbs.com/f1d3f5f8e935639ce808309299a869c8","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/359501806","isVote":1,"tweetType":1,"viewCount":1628,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3499891542239139","authorId":"3499891542239139","name":"小小虎儿儿","avatar":"https://static.tigerbbs.com/80d9d31f798bff492018b73985e9b525","crmLevel":1,"crmLevelSwitch":0,"idStr":"3499891542239139","authorIdStr":"3499891542239139"},"content":"💎👋是什么意思？","text":"💎👋是什么意思？","html":"💎👋是什么意思？"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":179393598,"gmtCreate":1626485012014,"gmtModify":1633926368266,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GOTU\">$Gaotu Techedu Inc.(GOTU)$</a>omg. Trash stock","listText":"<a href=\"https://laohu8.com/S/GOTU\">$Gaotu Techedu Inc.(GOTU)$</a>omg. Trash stock","text":"$Gaotu Techedu Inc.(GOTU)$omg. Trash stock","images":[{"img":"https://static.tigerbbs.com/6c28595f6d5a7673fb76b17b1c6320fd","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/179393598","isVote":1,"tweetType":1,"viewCount":1224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":323792151,"gmtCreate":1615373252973,"gmtModify":1703488053322,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Go higher higher","listText":"Go higher higher","text":"Go higher higher","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/323792151","repostId":"1162030727","repostType":4,"repost":{"id":"1162030727","kind":"news","pubTimestamp":1615371076,"share":"https://www.laohu8.com/m/news/1162030727?lang=&edition=full","pubTime":"2021-03-10 18:11","market":"us","language":"en","title":"The Equity-Gold Price Conundrum, Part 1: The Great Batsby","url":"https://stock-news.laohu8.com/highlight/detail?id=1162030727","media":"zerohedge","summary":"The relentless rally in equity markets has pushed valuations to extreme levels based on traditional ","content":"<p>The relentless rally in equity markets has pushed valuations to extreme levels based on traditional metrics. In this report, we analyze the two common arguments made by equity bulls on why this time is different and current valuations are justified. We find that either gold or equities are currently mispriced, as, a) both arguments would imply that gold should outperform stocks and b) if neither of the scenarios play out, equities are due for a substantial correction.</p><p><img src=\"https://static.tigerbbs.com/95f7609bf84bf26bd5d2443fa9a7de86\" tg-width=\"500\" tg-height=\"445\" referrerpolicy=\"no-referrer\">Amidst the global COVID-19 pandemic, equities had staggering rally over the past 12 months. The S&amp;P500 almost doubled in less than a year from a low of 2240 on March 23, 2020 to currently 3860 at the time of writing. In addition, some narrower indices have done even better. Particularly certain technology stocks have relentlessly risen amidst an environment of economic stress.</p><p>This has led to a sharp increase in the equities-to-gold price ratio (see Exhibit 1) even as economic growth has collapsed while the Fed increased its balance sheet at an unprecedented level.</p><p><img src=\"https://static.tigerbbs.com/a828b10b92375dfb19347e6c59314c83\" tg-width=\"500\" tg-height=\"405\" referrerpolicy=\"no-referrer\"></p><p>This increase in the equities-to-gold-ratio is not caused by gold performing poorly as prices for the yellow metal are up12% since the end of 2019. It’s simply a consequence of equities’ doing really well. But equity valuations according to traditional metrics have now approached extreme levels. For example, the total market cap to GDP (Buffet indicator) is currently at 193% (see exhibit 2), the highest on record, 50% above the peak during the dot.com bubble.</p><p><img src=\"https://static.tigerbbs.com/e64899d2c53b18cc97b2dce33717c9af\" tg-width=\"500\" tg-height=\"428\" referrerpolicy=\"no-referrer\">Moreover, global equities to GDP are also extremely high, currently at &gt;120% (see exhibit 3).</p><p><img src=\"https://static.tigerbbs.com/ef426becc1777204ae2f18e3c290e2e6\" tg-width=\"500\" tg-height=\"436\" referrerpolicy=\"no-referrer\">The Cyclically Adjusted Price Earnings Ratio, or CAPE, a measure developed by Robert Schiller, is also flashing red with the second highest reading in history going back to the late 1900s (see exhibit 4).</p><p><img src=\"https://static.tigerbbs.com/8cc92db52653acc17b59de9311c17bf0\" tg-width=\"500\" tg-height=\"442\" referrerpolicy=\"no-referrer\">Price to sales ratios also hit a record high (see Exhibit 5).</p><p><img src=\"https://static.tigerbbs.com/a119fa360112d18ced5d8efff557ebea\" tg-width=\"500\" tg-height=\"436\" referrerpolicy=\"no-referrer\">There are other indicators that suggest that equity prices have detached from underlying fundamentals. The put / call ratio on the CBOE has now reached the levels of the dot.com bubble (see Exhibit 6).</p><p><img src=\"https://static.tigerbbs.com/462aa5d4dee82e50792b2a4f6bbd70f8\" tg-width=\"500\" tg-height=\"389\" referrerpolicy=\"no-referrer\">We also saw an unprecedented inflow of new market participants. People with very little or no market exp4erience opened online brokerage accounts at an unprecedented speed during the global lockdowns. More than 10 million Americans opened a trading account in 2020 according to the Wall Street Journal.&nbsp; According to CNBC, ten percent of Americans bought a stock for the first time in the past 12 months, and a staggering twenty-two percent of Gen Z (currently 6-24 years old) opened a stock market account in the last 12 months.</p><p>And stocks are not the only assets that are skyrocketing. Cryptocurrencies, which since 2017 had temporarily lost their luster, are rallying at breakneck pace since the outbreak of the pandemic (see exhibit 7).</p><p><img src=\"https://static.tigerbbs.com/46a4f01c4a7404c0a7b196d39dac0a78\" tg-width=\"500\" tg-height=\"424\" referrerpolicy=\"no-referrer\">Judged on only those metrics, stock markets are clearly in a bubble. But is this time maybe really different as the bulls argue? In our view, there are only two ways that current stock prices could indeed be justified;</p><blockquote><b>1. The great Gatsby:</b>The pandemic, as negative as it was for economic activity near term, will be followed by a period of unprecedented economic expansion. Hence, GDP will rapidly rise and close the gap to equity prices. <b>2. The great inflation:</b>Stocks simply price in future inflation that eventually will come on the back of decades of ultra-low rates and central bank balance sheet expansion</blockquote><p>We will take a close look at the validity of those scenarios below. As we will show, these scenarios would require that we enter a multi-year period of extreme economic growth or inflation or a mix of both.&nbsp; However, we will show that gold should outperform stocks in either scenario. And if neither scenario comes true, then stock markets are due for a substantial correction. In that scenario, we would expect central banks to eventually intervene, which should ultimately also benefit gold. Hence, the fact that stocks have vastly outperformed gold over the past months is somewhat of a conundrum. But we are confident that this will reverse going forward.</p><p><b>Scenario one: The great Gatsby</b></p><p>Proponents of the great Gatsby scenario argue that, once the COVID19 pandemic is behind us as enough people are vaccinated and normality returns, economic activity will explode. The argumentation goes that there is a lot of pent-up demand as people were forced to save during the lockdowns and are eager to consume. This demand will be further fueled by stimulus checks (potentially in perpetuity, UBI). At the same time, governments around the world are rolling out huge green infrastructure programs, partially to combat climate change and partially to jump-start the economy.</p><p>While some of these deliberations have merit, there are a few important caveats. In our view, it is extremely unlikely for the economy to simply pick up where we left even if the current measures intended to contain the pandemic are completely removed. Many small businesses have closed forever or are about to close in the near term. The surviving businesses are aggressively cutting costs by a) laying off staff and b) trimming production. The former will impact on consumer demand going forward, the latter will impact on the businesses that are further up in the production chain. While there may be pent-up consumer demand from those who still have a job and saved a lot of money during lockdowns, there are also likely to be a lot of pent-up bankruptcies as many businesses have simply survived so far due to government intervention. Eventually many of those businesses will close. This is especially true in many European economies where governments de facto paid companies not to fire people.</p><p>The problem is compounded by the fact that the economy was already stuttering long before Coronavirus became a household name. The Fed had to aggressively reverse its hiking cycle already by 3Q2019 as markets started to turn sour. We believe that we are close to or already in a recession by late 2019. Hence, a simple return to the pre-COVID economy would mean back to a “normal” recession. Thus, the drivers for this apparent future multi-year super growth cycle have to be strong enough to offset these bearish factors as well.</p><p>Then there is the magnitude by how much the economy would have to expand to justify these kind of equity valuations. If you take a simple metric like market cap to GDP, then GDP would have to almost double from current levels to be in line with historical averages. That implies a nominal GDP of $40tn, or 86% above the levels before COVID (average 2019). Granted that market cap to GDP was already inflated to around 1.2 on average in the ten years prior to the pandemic due to ultra-low interest rates, a return to that average would still require nominal GDP to rise to $35tn or 63% from pre-COVID levels.</p><p>Even with a staggering 5% annual GDP growth and 2% inflation, it would still take more than seven years to get there. Are stocks really pricing in the year 2028 with 0% discount rate? And if so, what would be the fundamental driver to push stocks even higher from here? &nbsp;And is there even historic precedent for these kind of growth numbers? In the post WWII period, there have been only two instances where economic expansion was that high for a prolonged period (see Exhibit 8).</p><p>After WWII ended, the US saw a few years of moderate growth as government spending plummeted, followed by very high growth rates at around 6.9% between 1949 and 1953. This was possible as the US was one of the very few countries where none of the infrastructure had been destroyed and the rest of the world had to be rebuilt. However mathematically, even a repetition of the 1949-53 growth period over the coming years would not be enough to justify current stock prices as it lasted for “only” four years before the US fell into another recession.</p><p><img src=\"https://static.tigerbbs.com/e0e3916e88c1ee473c5ea235b229f969\" tg-width=\"500\" tg-height=\"420\" referrerpolicy=\"no-referrer\">From 1958-1969, the US economy was able to grow close to 5% with a brief monetary recession in 1960. In our view, this 1960s growth period is the only one that reflects the magnitude and length needed to get US GDP back in line with current equity prices. However, the economic environment of the 1960s looked very different from where we are now. More specifically, the US exited WWII with record debt to GPD of over 100%. However, it then immediately cut spending (which resulted in the slower growth rates in the immediate years after WWII) and reduced debt. Inflation also picked up, which, to some extent, helped reducing debt even further[1]. By 1959, the US government had reduced its debt held by the public to 44%, and it dropped to 27% by the end of the 60s (see exhibit 9).</p><p><img src=\"https://static.tigerbbs.com/4ee79afe5f74fa39abc86b197930c486\" tg-width=\"500\" tg-height=\"422\" referrerpolicy=\"no-referrer\">Additionally, 10-year treasury rates average at around 5% during this entire growth period. This is a stark contrast to the 1.5% we are seeing now (which already seem to rattle markets). Furthermore, the FED has no room to the downside, as Fed funds rates are already at zero percent. Hence, the only monetary stimulus that is left is via continued and even more extreme QE. However, as we have shown many times before (see&nbsp;Gold Price Framework Vol. 2: The energy side of the equation,&nbsp;<i>28 May 2018</i>), QE has always a huge and direct effect on gold prices, and gold is currently not pricing any of that in. Instead, the equity and gold markets seem to be pricing in economic expansion that is driven by anything but more monetary stimulus.</p><p>Another theme of the great Gatsby scenario is that governments will unleash massive transformation towards a greener future. This will lead to huge infrastructure investments in energy, transportation and commodity space, create jobs and unlock economic growth. While we believe that this is likely to be true, what the market seems to ignore is that this can only be financed with more government debt. Central banks will ultimately have to buy that debt, which has the same effect as QE as it leads to a growing balance sheet. And as we have outlined before, higher QE leads to higher gold prices. So again, if markets are pricing in economic expansion on the back of a “green new deal”, they seem to wrongly assume that this can be done without an effect on gold price.</p><p>Lastly, there is the idea that the COVID relief checks will continue indefinitely, de facto introducing a sort of Universal Basic Income (UBI). This would have an effect on consumer spending and, thus, corporate revenues. However, currently the US is running the largest deficit in history. If UBI becomes a reality, this would also have to be entirely financed via debt. As mentioned before, markets are not pricing this in, otherwise we would see an effect on gold.</p><p><b>Thus, the equity-gold conundrum doesn’t disappear in the great Gatsby scenario. In fact, we think that if we see strong economic growth over the coming years, it will entirely be debt financed and as a consequence gold should outperform stocks, not the other way around.</b></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Equity-Gold Price Conundrum, Part 1: The Great Batsby</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Equity-Gold Price Conundrum, Part 1: The Great Batsby\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-10 18:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/equity-gold-price-conundrum-part-1-great-batsby?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohege%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The relentless rally in equity markets has pushed valuations to extreme levels based on traditional metrics. In this report, we analyze the two common arguments made by equity bulls on why this time ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/equity-gold-price-conundrum-part-1-great-batsby?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohege%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.zerohedge.com/markets/equity-gold-price-conundrum-part-1-great-batsby?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohege%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162030727","content_text":"The relentless rally in equity markets has pushed valuations to extreme levels based on traditional metrics. In this report, we analyze the two common arguments made by equity bulls on why this time is different and current valuations are justified. We find that either gold or equities are currently mispriced, as, a) both arguments would imply that gold should outperform stocks and b) if neither of the scenarios play out, equities are due for a substantial correction.Amidst the global COVID-19 pandemic, equities had staggering rally over the past 12 months. The S&P500 almost doubled in less than a year from a low of 2240 on March 23, 2020 to currently 3860 at the time of writing. In addition, some narrower indices have done even better. Particularly certain technology stocks have relentlessly risen amidst an environment of economic stress.This has led to a sharp increase in the equities-to-gold price ratio (see Exhibit 1) even as economic growth has collapsed while the Fed increased its balance sheet at an unprecedented level.This increase in the equities-to-gold-ratio is not caused by gold performing poorly as prices for the yellow metal are up12% since the end of 2019. It’s simply a consequence of equities’ doing really well. But equity valuations according to traditional metrics have now approached extreme levels. For example, the total market cap to GDP (Buffet indicator) is currently at 193% (see exhibit 2), the highest on record, 50% above the peak during the dot.com bubble.Moreover, global equities to GDP are also extremely high, currently at >120% (see exhibit 3).The Cyclically Adjusted Price Earnings Ratio, or CAPE, a measure developed by Robert Schiller, is also flashing red with the second highest reading in history going back to the late 1900s (see exhibit 4).Price to sales ratios also hit a record high (see Exhibit 5).There are other indicators that suggest that equity prices have detached from underlying fundamentals. The put / call ratio on the CBOE has now reached the levels of the dot.com bubble (see Exhibit 6).We also saw an unprecedented inflow of new market participants. People with very little or no market exp4erience opened online brokerage accounts at an unprecedented speed during the global lockdowns. More than 10 million Americans opened a trading account in 2020 according to the Wall Street Journal.  According to CNBC, ten percent of Americans bought a stock for the first time in the past 12 months, and a staggering twenty-two percent of Gen Z (currently 6-24 years old) opened a stock market account in the last 12 months.And stocks are not the only assets that are skyrocketing. Cryptocurrencies, which since 2017 had temporarily lost their luster, are rallying at breakneck pace since the outbreak of the pandemic (see exhibit 7).Judged on only those metrics, stock markets are clearly in a bubble. But is this time maybe really different as the bulls argue? In our view, there are only two ways that current stock prices could indeed be justified;1. The great Gatsby:The pandemic, as negative as it was for economic activity near term, will be followed by a period of unprecedented economic expansion. Hence, GDP will rapidly rise and close the gap to equity prices. 2. The great inflation:Stocks simply price in future inflation that eventually will come on the back of decades of ultra-low rates and central bank balance sheet expansionWe will take a close look at the validity of those scenarios below. As we will show, these scenarios would require that we enter a multi-year period of extreme economic growth or inflation or a mix of both.  However, we will show that gold should outperform stocks in either scenario. And if neither scenario comes true, then stock markets are due for a substantial correction. In that scenario, we would expect central banks to eventually intervene, which should ultimately also benefit gold. Hence, the fact that stocks have vastly outperformed gold over the past months is somewhat of a conundrum. But we are confident that this will reverse going forward.Scenario one: The great GatsbyProponents of the great Gatsby scenario argue that, once the COVID19 pandemic is behind us as enough people are vaccinated and normality returns, economic activity will explode. The argumentation goes that there is a lot of pent-up demand as people were forced to save during the lockdowns and are eager to consume. This demand will be further fueled by stimulus checks (potentially in perpetuity, UBI). At the same time, governments around the world are rolling out huge green infrastructure programs, partially to combat climate change and partially to jump-start the economy.While some of these deliberations have merit, there are a few important caveats. In our view, it is extremely unlikely for the economy to simply pick up where we left even if the current measures intended to contain the pandemic are completely removed. Many small businesses have closed forever or are about to close in the near term. The surviving businesses are aggressively cutting costs by a) laying off staff and b) trimming production. The former will impact on consumer demand going forward, the latter will impact on the businesses that are further up in the production chain. While there may be pent-up consumer demand from those who still have a job and saved a lot of money during lockdowns, there are also likely to be a lot of pent-up bankruptcies as many businesses have simply survived so far due to government intervention. Eventually many of those businesses will close. This is especially true in many European economies where governments de facto paid companies not to fire people.The problem is compounded by the fact that the economy was already stuttering long before Coronavirus became a household name. The Fed had to aggressively reverse its hiking cycle already by 3Q2019 as markets started to turn sour. We believe that we are close to or already in a recession by late 2019. Hence, a simple return to the pre-COVID economy would mean back to a “normal” recession. Thus, the drivers for this apparent future multi-year super growth cycle have to be strong enough to offset these bearish factors as well.Then there is the magnitude by how much the economy would have to expand to justify these kind of equity valuations. If you take a simple metric like market cap to GDP, then GDP would have to almost double from current levels to be in line with historical averages. That implies a nominal GDP of $40tn, or 86% above the levels before COVID (average 2019). Granted that market cap to GDP was already inflated to around 1.2 on average in the ten years prior to the pandemic due to ultra-low interest rates, a return to that average would still require nominal GDP to rise to $35tn or 63% from pre-COVID levels.Even with a staggering 5% annual GDP growth and 2% inflation, it would still take more than seven years to get there. Are stocks really pricing in the year 2028 with 0% discount rate? And if so, what would be the fundamental driver to push stocks even higher from here?  And is there even historic precedent for these kind of growth numbers? In the post WWII period, there have been only two instances where economic expansion was that high for a prolonged period (see Exhibit 8).After WWII ended, the US saw a few years of moderate growth as government spending plummeted, followed by very high growth rates at around 6.9% between 1949 and 1953. This was possible as the US was one of the very few countries where none of the infrastructure had been destroyed and the rest of the world had to be rebuilt. However mathematically, even a repetition of the 1949-53 growth period over the coming years would not be enough to justify current stock prices as it lasted for “only” four years before the US fell into another recession.From 1958-1969, the US economy was able to grow close to 5% with a brief monetary recession in 1960. In our view, this 1960s growth period is the only one that reflects the magnitude and length needed to get US GDP back in line with current equity prices. However, the economic environment of the 1960s looked very different from where we are now. More specifically, the US exited WWII with record debt to GPD of over 100%. However, it then immediately cut spending (which resulted in the slower growth rates in the immediate years after WWII) and reduced debt. Inflation also picked up, which, to some extent, helped reducing debt even further[1]. By 1959, the US government had reduced its debt held by the public to 44%, and it dropped to 27% by the end of the 60s (see exhibit 9).Additionally, 10-year treasury rates average at around 5% during this entire growth period. This is a stark contrast to the 1.5% we are seeing now (which already seem to rattle markets). Furthermore, the FED has no room to the downside, as Fed funds rates are already at zero percent. Hence, the only monetary stimulus that is left is via continued and even more extreme QE. However, as we have shown many times before (see Gold Price Framework Vol. 2: The energy side of the equation, 28 May 2018), QE has always a huge and direct effect on gold prices, and gold is currently not pricing any of that in. Instead, the equity and gold markets seem to be pricing in economic expansion that is driven by anything but more monetary stimulus.Another theme of the great Gatsby scenario is that governments will unleash massive transformation towards a greener future. This will lead to huge infrastructure investments in energy, transportation and commodity space, create jobs and unlock economic growth. While we believe that this is likely to be true, what the market seems to ignore is that this can only be financed with more government debt. Central banks will ultimately have to buy that debt, which has the same effect as QE as it leads to a growing balance sheet. And as we have outlined before, higher QE leads to higher gold prices. So again, if markets are pricing in economic expansion on the back of a “green new deal”, they seem to wrongly assume that this can be done without an effect on gold price.Lastly, there is the idea that the COVID relief checks will continue indefinitely, de facto introducing a sort of Universal Basic Income (UBI). This would have an effect on consumer spending and, thus, corporate revenues. However, currently the US is running the largest deficit in history. If UBI becomes a reality, this would also have to be entirely financed via debt. As mentioned before, markets are not pricing this in, otherwise we would see an effect on gold.Thus, the equity-gold conundrum doesn’t disappear in the great Gatsby scenario. In fact, we think that if we see strong economic growth over the coming years, it will entirely be debt financed and as a consequence gold should outperform stocks, not the other way around.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":107764648,"gmtCreate":1620540922784,"gmtModify":1634198132790,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Go for it","listText":"Go for it","text":"Go for it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/107764648","repostId":"1106882084","repostType":4,"isVote":1,"tweetType":1,"viewCount":280,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374257611,"gmtCreate":1619450791633,"gmtModify":1634273344074,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>cry tiger","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>cry tiger","text":"$Tiger Brokers(TIGR)$cry tiger","images":[{"img":"https://static.tigerbbs.com/673586a63f14b099924e7a415a100291","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/374257611","isVote":1,"tweetType":1,"viewCount":507,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3573719572697574","authorId":"3573719572697574","name":"张大发同学","avatar":"https://static.tigerbbs.com/3fd7bf41ad5567dd93aae0ed6e28e6fe","crmLevel":2,"crmLevelSwitch":0,"idStr":"3573719572697574","authorIdStr":"3573719572697574"},"content":"我从31一直加到14回血的","text":"我从31一直加到14回血的","html":"我从31一直加到14回血的"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":894990649,"gmtCreate":1628780633881,"gmtModify":1631892264507,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way","listText":"All the way","text":"All the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/894990649","repostId":"2158325931","repostType":4,"repost":{"id":"2158325931","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628776169,"share":"https://www.laohu8.com/m/news/2158325931?lang=&edition=full","pubTime":"2021-08-12 21:49","market":"us","language":"en","title":"BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster","url":"https://stock-news.laohu8.com/highlight/detail?id=2158325931","media":"Tiger Newspress","summary":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previo","content":"<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-12 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158325931","content_text":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.\n\nBioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.\nThe WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.\nThere is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.\nBioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.\nThe conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.\nPfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":952,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138407381,"gmtCreate":1621952095743,"gmtModify":1634185190253,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Go up and down","listText":"Go up and down","text":"Go up and down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/138407381","repostId":"1150619526","repostType":4,"repost":{"id":"1150619526","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1621951262,"share":"https://www.laohu8.com/m/news/1150619526?lang=&edition=full","pubTime":"2021-05-25 22:01","market":"us","language":"en","title":"Moderna shares once gained more than 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150619526","media":"Tiger Newspress","summary":"Today Moderna shares once gained more than 4%. Modernasaid Tuesday its Covid-19 vaccine was 100% eff","content":"<p>Today&nbsp;Moderna&nbsp;shares&nbsp;once&nbsp;gained&nbsp;more&nbsp;than&nbsp;4%.&nbsp;</p><p><img src=\"https://static.tigerbbs.com/c4d4545f5ddaf3cc95708b587f6eedb0\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\">Modernasaid Tuesday its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behindPfizer's to demonstrate high efficacy in younger age groups.</p><p>The company said it plans to ask the Food and Drug Administration to expand the emergency use of its Covid vaccine for teens early next month. If approved, it would likely dramatically expand the number of shots available to middle and high school students ahead of the next school year. Pfizer and German partnerBioNTechwere clearedto use their vaccine for 12- to 15-year-olds earlier this month.</p><p>\"We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents,\" Moderna CEO Stephane Bancel said in a press release. \"We remain committed to doing our part to help end the COVID-19 pandemic.\"</p><p>The two-dose vaccine, which is given four weeks apart, is already authorized for adults.</p><p>U.S. regulators are expected to grant Moderna's request for use in teens. The approval process could take about a month, just in time for some summer activities and fall classes if Moderna submits the data by early June. Pfizer and BioNTech requested expanded use of their shot in adolescents on April 9, for example, and were authorized by the FDA on May 10.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna shares once gained more than 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna shares once gained more than 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-25 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Today&nbsp;Moderna&nbsp;shares&nbsp;once&nbsp;gained&nbsp;more&nbsp;than&nbsp;4%.&nbsp;</p><p><img src=\"https://static.tigerbbs.com/c4d4545f5ddaf3cc95708b587f6eedb0\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\">Modernasaid Tuesday its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behindPfizer's to demonstrate high efficacy in younger age groups.</p><p>The company said it plans to ask the Food and Drug Administration to expand the emergency use of its Covid vaccine for teens early next month. If approved, it would likely dramatically expand the number of shots available to middle and high school students ahead of the next school year. Pfizer and German partnerBioNTechwere clearedto use their vaccine for 12- to 15-year-olds earlier this month.</p><p>\"We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents,\" Moderna CEO Stephane Bancel said in a press release. \"We remain committed to doing our part to help end the COVID-19 pandemic.\"</p><p>The two-dose vaccine, which is given four weeks apart, is already authorized for adults.</p><p>U.S. regulators are expected to grant Moderna's request for use in teens. The approval process could take about a month, just in time for some summer activities and fall classes if Moderna submits the data by early June. Pfizer and BioNTech requested expanded use of their shot in adolescents on April 9, for example, and were authorized by the FDA on May 10.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150619526","content_text":"Today Moderna shares once gained more than 4%. Modernasaid Tuesday its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behindPfizer's to demonstrate high efficacy in younger age groups.The company said it plans to ask the Food and Drug Administration to expand the emergency use of its Covid vaccine for teens early next month. If approved, it would likely dramatically expand the number of shots available to middle and high school students ahead of the next school year. Pfizer and German partnerBioNTechwere clearedto use their vaccine for 12- to 15-year-olds earlier this month.\"We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents,\" Moderna CEO Stephane Bancel said in a press release. \"We remain committed to doing our part to help end the COVID-19 pandemic.\"The two-dose vaccine, which is given four weeks apart, is already authorized for adults.U.S. regulators are expected to grant Moderna's request for use in teens. The approval process could take about a month, just in time for some summer activities and fall classes if Moderna submits the data by early June. Pfizer and BioNTech requested expanded use of their shot in adolescents on April 9, for example, and were authorized by the FDA on May 10.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":245,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":371497498,"gmtCreate":1618964621214,"gmtModify":1631887103988,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNOW\">$Snowflake(SNOW)$</a>winter snow","listText":"<a href=\"https://laohu8.com/S/SNOW\">$Snowflake(SNOW)$</a>winter snow","text":"$Snowflake(SNOW)$winter snow","images":[{"img":"https://static.tigerbbs.com/67a9078debe32abd7ba2780179c8e0d3","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/371497498","isVote":1,"tweetType":1,"viewCount":490,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":357781563,"gmtCreate":1617299401052,"gmtModify":1634521525203,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CNEY\">$CN Energy Group Inc.(CNEY)$</a>when going up","listText":"<a href=\"https://laohu8.com/S/CNEY\">$CN Energy Group Inc.(CNEY)$</a>when going up","text":"$CN Energy Group Inc.(CNEY)$when going up","images":[{"img":"https://static.tigerbbs.com/3fc6bb6b87b49fccd6b63135ae46cbf4","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/357781563","isVote":1,"tweetType":1,"viewCount":518,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":152079134,"gmtCreate":1625246233128,"gmtModify":1633942097458,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Go there","listText":"Go there","text":"Go there","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/152079134","repostId":"2148870441","repostType":4,"isVote":1,"tweetType":1,"viewCount":217,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187424559,"gmtCreate":1623762701771,"gmtModify":1631885484644,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Time to buy dip","listText":"Time to buy dip","text":"Time to buy dip","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/187424559","repostId":"1128180606","repostType":4,"isVote":1,"tweetType":1,"viewCount":415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":100297927,"gmtCreate":1619615846869,"gmtModify":1634211332334,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/UXIN\">$Uxin(UXIN)$</a>今天 上 还是 下。 我猜 最高 2.35","listText":"<a href=\"https://laohu8.com/S/UXIN\">$Uxin(UXIN)$</a>今天 上 还是 下。 我猜 最高 2.35","text":"$Uxin(UXIN)$今天 上 还是 下。 我猜 最高 2.35","images":[{"img":"https://static.tigerbbs.com/629216e611662590e3ce7e2d386c5260","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/100297927","isVote":1,"tweetType":1,"viewCount":1142,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":376973381,"gmtCreate":1619084925543,"gmtModify":1634288686487,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/EBON\">$Ebang International Holdings Inc.(EBON)$</a>im trapped","listText":"<a href=\"https://laohu8.com/S/EBON\">$Ebang International Holdings Inc.(EBON)$</a>im trapped","text":"$Ebang International Holdings Inc.(EBON)$im trapped","images":[{"img":"https://static.tigerbbs.com/68af1c5266df1fe069d79aa9b99674ae","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/376973381","isVote":1,"tweetType":1,"viewCount":761,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":359503535,"gmtCreate":1616408796327,"gmtModify":1634526006229,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Way to go","listText":"Way to go","text":"Way to go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/359503535","repostId":"1163016573","repostType":4,"isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":362955841,"gmtCreate":1614590815883,"gmtModify":1703478545378,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>huat huat up up","listText":"<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>huat huat up up","text":"$GameStop(GME)$huat huat up up","images":[{"img":"https://static.tigerbbs.com/b2785f2f37290160a21ff3d7037d647d","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/362955841","isVote":1,"tweetType":1,"viewCount":365,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":361551447,"gmtCreate":1614248726189,"gmtModify":1634550490977,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>pro","listText":"<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>pro","text":"$GameStop(GME)$pro","images":[{"img":"https://static.tigerbbs.com/e240be0ebcb9e5519b1c89416373376c","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/361551447","isVote":1,"tweetType":1,"viewCount":492,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":175429165,"gmtCreate":1627047351657,"gmtModify":1631892264530,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"To the moon","listText":"To the moon","text":"To the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/175429165","repostId":"2153498346","repostType":4,"isVote":1,"tweetType":1,"viewCount":3092,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146530690,"gmtCreate":1626089026910,"gmtModify":1633930280528,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Good read","listText":"Good read","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/146530690","repostId":"1114863871","repostType":4,"isVote":1,"tweetType":1,"viewCount":501,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":122831399,"gmtCreate":1624609651711,"gmtModify":1633950576674,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Predict do not cost money","listText":"Predict do not cost money","text":"Predict do not cost money","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/122831399","repostId":"1102706768","repostType":4,"repost":{"id":"1102706768","kind":"news","pubTimestamp":1624604893,"share":"https://www.laohu8.com/m/news/1102706768?lang=&edition=full","pubTime":"2021-06-25 15:08","market":"us","language":"en","title":"Prominent investor Scott Minerd predicts the 'real bottom' in the price of bitcoin","url":"https://stock-news.laohu8.com/highlight/detail?id=1102706768","media":"CNBC","summary":"Prominent investor Scott Minerd told CNBC that the fall inbitcoinis not yet over and shared his fore","content":"<div>\n<p>Prominent investor Scott Minerd told CNBC that the fall inbitcoinis not yet over and shared his forecast for where the “real bottom” in the cryptocurrency’s price could be.\nMinerd told CNBC’s Nancy ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/25/guggenheims-scott-minerd-on-real-bottom-of-bitcoin-price.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Prominent investor Scott Minerd predicts the 'real bottom' in the price of bitcoin</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProminent investor Scott Minerd predicts the 'real bottom' in the price of bitcoin\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 15:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/25/guggenheims-scott-minerd-on-real-bottom-of-bitcoin-price.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Prominent investor Scott Minerd told CNBC that the fall inbitcoinis not yet over and shared his forecast for where the “real bottom” in the cryptocurrency’s price could be.\nMinerd told CNBC’s Nancy ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/25/guggenheims-scott-minerd-on-real-bottom-of-bitcoin-price.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GBTC":"Grayscale Bitcoin Trust ETF"},"source_url":"https://www.cnbc.com/2021/06/25/guggenheims-scott-minerd-on-real-bottom-of-bitcoin-price.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1102706768","content_text":"Prominent investor Scott Minerd told CNBC that the fall inbitcoinis not yet over and shared his forecast for where the “real bottom” in the cryptocurrency’s price could be.\nMinerd told CNBC’s Nancy Hungerford on Thursday that every “major” run-up in bitcoin has been followed by a correction of around 80%.\nEarlier this year, bitcoin prices more than doubled to reach an all-time high of around $65,000 in April. The cryptocurrency currently last traded at around $34,000 per unit, which is more than 40% off that record level.\nMinerd had predicted“a major correction”in bitcoin prior to the latest plunge.\n“The real bottom, when you look at the technicals, $10,000 would be the real bottom. You know, that’s probably a little extreme. So I would say [$15,000],” said Minerd, global chief investment officer of Guggenheim Partners.\n“If it got to $20,000, I wouldn’t be in a hurry to buy it because when markets like this wash out, it … usually takes a couple of years of consolidation. So I don’t think people need to be anxious to be putting money in bitcoin right now,” he added.\nMinerd said the declines in bitcoin have come as central banks have started to ease the amount of money they inject into the economy. He added that the easing in money supply is not yet done — implying that the cryptocurrency has more room to fall.\nBut Minerd said he remains bullish about bitcoin over the long term as more institutional money flows into the cryptocurrency. Until that happens, bitcoin remains “a highly volatile speculative asset,” he added.\nThe investor hadpreviously shared his predictionthat bitcoin would eventually reach $400,000 to $600,000 per unit.","news_type":1,"symbols_score_info":{"GBTC":0.9}},"isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129612807,"gmtCreate":1624370789209,"gmtModify":1634007127875,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way down","listText":"All the way down","text":"All the way down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/129612807","repostId":"1143470407","repostType":4,"isVote":1,"tweetType":1,"viewCount":358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}